HealthEquity Inc HQY 深 滬
已收盤 02-06 16:00:00 美东时间
79.45
+0.230
+0.29%
華盛通- 最 高80.17
- 今 開79.70
- 成交量 116.57万股
- 最 低 77.98
- 昨 收 79.22
- 總市值 67.88亿
- 52周最高 116.65
- 市盈率 靜 72.98
- 換手率 1.36%
- 52周最低 74.07
- 委 比 43.99%
- 總股本 8543.63万
- 歷史最高 116.65
- 量 比 1.08
- 振 幅 2.76%
- 歷史最低 15.80
- 每 手 1
- 風險率 7.89%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Exploring Centene's Earnings Expectations
Centene (NYSE:CNC) is set to give its latest quarterly earnings report on Frida...
02-05 22:01
Earnings Outlook For UnitedHealth Group
UnitedHealth Group (NYSE:UNH) will release its quarterly earnings report on Tue...
01-26 22:01
HealthEquity shares are trading lower. The company reaffirmed its FY26 guidance and initiated FY27 sales guidance below estimates.
HealthEquity shares are trading lower. The company reaffirmed its FY26 guidance...
01-13 03:59
HealthEquity Reaffirms Fiscal 2026 Outlook, Expects Fiscal 2027 Revenue Of ~$1.41B
HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian by number of accounts and leading provider of complimentary consumer-directed benefits
01-12 21:55
HealthEquity Sees FY2027 Sales $1.380B-$1.410B vs $1.418B Est
HealthEquity (NASDAQ:HQY) sees FY2027 sales of $1.380 billion-$1.410 billion vs $1.418 billion analyst estimate.
01-12 21:52
美股大行评级 | 瑞穗上调英伟达、谷歌、美光科技、SanDisk多家科技股目标价；中金首予诺和诺德"跑赢大市"评级，目标价73.5美元
今日重点评级关注：Needham：维持Cartesian Therapeutics"买入"评级，目标价从40美元升至42美元；Piper Sandler：维持Acrivon Therapeutics"超配"评级，目标价从6美元升至8美元
01-12 14:09
HealthEquity Announces Fiscal Year 2027 Outlook Presentation at J.P. Morgan Healthcare Conference
HealthEquity, the largest HSA custodian in the U.S., provided its financial outlook for the fiscal year ending Jan. 31, 2027, projecting revenues of $1.38 billion to $1.41 billion, an Adjusted EBITDA margin of 43.8% to 44.3%, and a 3.75% yield on HSA Cash. CEO Scott Cutler highlighted the company's progress in modernizing its business and its position to drive growth in the HSA market, supported by its network of over 200 partners. The company wi...
01-12 13:50
What 8 Analyst Ratings Have To Say About HealthEquity
HealthEquity (NASDAQ:HQY) has been analyzed by 8 analysts in the last three mon...
01-09 21:01
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
Keybanc Maintains Overweight on HealthEquity, Raises Price Target to $125
Keybanc analyst Scott Schoenhaus maintains HealthEquity (NASDAQ:HQY) with a Overweight and raises the price target from $120 to $125.
01-08 22:14
